Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chinese herbal medicine granules (CHMG) is a standardized polyherbal formulation developed by researchers at Heilongjiang University of Chinese Medicine. It is specifically investigated for its efficacy in treating infertility associated with polycystic ovary syndrome (PCOS). In clinical trials, it is often administered in combination with letrozole, an aromatase inhibitor. The mechanism of CHMG is thought to involve the regulation of the hypothalamic-pituitary-ovarian (HPO) axis, reduction of insulin resistance, and improvement of the follicular microenvironment, thereby enhancing ovulation rates and live birth outcomes in anovulatory women. The formulation typically includes a mixture of traditional Chinese herbs such as *Cuscuta chinensis*, *Taxillus chinensis*, and *Lycium barbarum*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chinese herbal medicine granules.